What is the primary purpose of these new Executive Severance Agreements?

The primary purpose is to retain and motivate key management personnel by providing them with defined severance benefits and equity acceleration in the event of their employment termination under specific circumstances, especially if a "Change of Control" occurs. This aims to ensure leadership stability and continuity for Microchip.

What benefits are executives entitled to if their employment is terminated following a "Change of Control"?

Benefits vary by executive role. For the CEO, CFO, and VP of Worldwide Sales, this typically includes two years of base salary and bonus continuation, and two years of medical/dental benefit continuation. Other named executives generally receive one year of base salary and bonus continuation, and one year of medical/dental benefit continuation. All these benefits are subject to specific conditions and limitations, such as the executive not finding new employment.

Does the agreement guarantee employment for these executives?

No, the Executive Severance Agreements are not employment contracts. They do not specify an employment term, compensation levels, or other standard terms and conditions of employment. They only define benefits that become payable upon certain termination events or a Change of Control.

What is a "Change of Control" in the context of these agreements?

The filing does not provide a specific definition of "Change of Control" but refers to it as being defined within the agreements themselves. Generally, in such agreements, a "Change of Control" refers to events like a merger, acquisition, or significant change in the ownership or control of the company's stock or assets.

MCHP/MCHPP 8-K: Material Agreements

Summary

Microchip Technology Incorporated (MCHP) filed an 8-K on October 27, 2006, detailing the entry into new Executive Severance Agreements for several key officers, including the CEO, CFO, and VPs of Sales, Fab Operations, and other divisions. These agreements, effective October 23, 2006, are designed to retain and motivate top management, particularly in the event of a "Change of Control." The agreements outline specific severance benefits, including salary continuation, bonus payments, and extended medical/dental benefits, contingent upon termination under certain circumstances within a "Change of Control Period." They also include provisions for the accelerated vesting of equity compensation for certain executives upon a Change of Control or termination. Additionally, the filing reports the promotion of Ganesh Moorthy to Executive Vice President, effective November 6, 2006, with a salary increase. These actions indicate a proactive approach by Microchip's Board of Directors to secure its leadership team amidst potential corporate transitions, providing a safety net for executives while aiming to ensure continuity and stability for the company.

Key Highlights

1Microchip Technology entered into new Executive Severance Agreements with key executive officers, including the CEO, CFO, and several Vice Presidents.
2The agreements are designed to incentivize and retain executive talent, particularly in scenarios involving a "Change of Control."
3Severance benefits include continued base salary, bonus payments, and health benefits for specified periods following a termination under defined circumstances.
4For top executives (CEO, CFO, VP of Worldwide Sales), severance is generally two years of salary and bonus, one year for others, with differing benefit continuation periods.
5Equity compensation held by certain executives will fully vest upon a "Change of Control" or termination during the "Change of Control Period."
6The agreements replace prior severance arrangements for the CEO, CFO, and VP of Worldwide Sales.
7Ganesh Moorthy was promoted to Executive Vice President with an increased salary, effective November 6, 2006.

MICROCHIP TECHNOLOGY INC 8-K Report, Material Agreement (Oct 27, 2006)

Summary

Key Highlights

Frequently Asked Questions